The Predictive Value of Semi-quantitative Index of99mTc-3PRGD2 SPECT/CTfor Patients with HER2 Positive Breast Cancer

被引:0
|
作者
Liu, Haiyan [1 ]
Li, Wanting [1 ]
Cui, Yongping [4 ]
Qin, Lijun [1 ,5 ]
Wu, Zhifang [1 ,3 ]
Ren, Yuan [5 ]
Liu, Jing [2 ]
Zhang, Guochen [6 ]
Hu, Guang [1 ,3 ]
Wang, Hongliang [1 ,3 ]
Cui, Yali [1 ]
Niu, Jing [1 ]
Li, Sijin [1 ,3 ]
机构
[1] Shanxi Med Univ, Hosp 1, Taiyuan, Shanxi, Peoples R China
[2] Shanxi Med Univ, Hosp 1, Dept Gen Surg, Taiyuan, Shanxi, Peoples R China
[3] Shanxi Med Univ, Mol Imaging Precis Med Collaborat Innovat, Taiyuan, Shanxi, Peoples R China
[4] Shanxi Med Univ, Translat Med Res Ctr, Taiyuan, Shanxi, Peoples R China
[5] Shanxi Med Univ, Tumor Hosp, Taiyuan, Shanxi, Peoples R China
[6] Shanxi Med Univ, Tumor Hosp, Dept Breast Surg, Taiyuan, Shanxi, Peoples R China
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
1367
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Diagnostic value of 99mTc-3PRGD2 scintimammography for differentiation of malignant from benign breast lesions: Comparison of visual and semi-quantitative analysis
    Chen, Qianqian
    Xie, Qian
    Zhao, Min
    Chen, Bin
    Gao, Shi
    Zhang, Haishan
    Xing, Hua
    Ma, Qingjie
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2015, 18 (03) : 193 - 198
  • [2] The predictive value of HER2 in breast cancer
    Piccart, M
    Lohrisch, C
    Di Leo, A
    Larsimont, D
    ONCOLOGY, 2001, 61 : 73 - 82
  • [3] 99mTc-ABH2 SPECT/CT for Imaging HER2 expression in Breast Cancer: A Preliminary Study
    Zhang, Yuwei
    Wang, Peipei
    Jing, Hongli
    Li, Fang
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [4] Predictive value of quantitative HER2 and HER3 levels combined with downstream signaling markers in HER2-positive advanced breast cancer patients treated with lapatinib
    Duchnowska, R.
    Sperinde, J.
    Czartoryska-Arlukowicz, B.
    Mysliwiec, P.
    Winslow, J.
    Radecka, B.
    Petropoulos, C.
    Demlova, R.
    Orlikowska, M.
    Kowalczyk, A.
    Lang, I.
    Ziolkowska, B.
    Debska-Szmich, S.
    Merdalska, M.
    Grela-Wojewoda, A.
    Zawrocki, A.
    Biernat, W.
    Huang, W.
    Jassem, J.
    CANCER RESEARCH, 2017, 77
  • [5] Evaluation of Standard Uptake Value of 99mTc-3PRGD2 SPECT/CT in Lung Cancer Diagnosis
    Shi, Ximin
    Huo, Li
    Zhao, Xinming
    Li, Mei
    Bian, Yanzhu
    Miao, Weibing
    Jia, Bing
    Wang, Jiaxing
    Wang, Fan
    Li, Fang
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [6] Non-Invasive Monitoring of HER2 Expression in Breast Cancer Patients with 99mTc-Affibody SPECT/CT
    Cai, Jiong
    Li, Xin
    Mao, Feng
    Wang, Pan
    Luo, Yaping
    Zheng, Kun
    Li, Fang
    Zhu, Zhaohui
    IRANIAN JOURNAL OF RADIOLOGY, 2020, 17 (01)
  • [7] Prognostic and predictive value of phosphorylated HER2, HER3 and PTEN expression in patients with HER2-positive breast cancer treated with trastuzumab
    Debska-Szmich, S.
    Kusinska, R.
    Krakowska, M.
    Czyzykowski, R.
    Czernek, U.
    Zadrozna, A.
    Potemski, P.
    ANNALS OF ONCOLOGY, 2019, 30
  • [8] Predictive value of quantitative HER2, HER3 and p95HER2 levels in HER2-positive advanced breast cancer patients treated with lapatinib following progression on trastuzumab
    Duchnowska, Renata
    Sperinde, Jeff
    Czartoryska-Arlukowicz, Bogumila
    Mysliwiec, Paulina
    Winslow, John
    Radecka, Barbara
    Petropoulos, Christos
    Demlova, Regina
    Orlikowska, Marlena
    Kowalczyk, Anna
    Lang, Istvan
    Ziolkowska, Barbara
    Debska-Szmich, Sylwia
    Merdalska, Monika
    Grela-Wojewoda, Aleksandra
    Zawrocki, Anton
    Biernat, Wojciech
    Huang, Weidong
    Jassem, Jacek
    ONCOTARGET, 2017, 8 (61) : 104149 - 104159
  • [9] Treatment of HER2 positive breast cancer patients
    Matos, Erika
    ZDRAVNISKI VESTNIK-SLOVENIAN MEDICAL JOURNAL, 2012, 81 (03): : 236 - 245
  • [10] Predictive Value of HER2 Fluorescence In Situ Hybridization (FISH) Result in HER2 Positive Breast Cancer Response to Neoadjuvant Therapy
    Zhao, Jing
    Suo, Aili
    Zhang, Chao
    Shi, Quiying
    Wei, Zhimin
    Li, Zaibo
    Li, Xiaoxian
    MODERN PATHOLOGY, 2019, 32